ANGLE Investor Relations Material
Latest events
H2 2024
ANGLE
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from ANGLE plc
Access all reports
ANGLE plc is a British medical diagnostics company focused on developing liquid biopsy solutions for cancer diagnostics. The company’s proprietary Parsortix system enables the capture and analysis of circulating tumor cells (CTCs) from patient blood samples, allowing for non-invasive cancer detection, monitoring, and personalized treatment insights. ANGLE’s technology is used in clinical research and trials, supporting advancements in oncology by providing real-time data on tumor progression and response to therapy. The company is headquartered in Guildford, United Kingdom, and its shares are listed on the London Stock Exchange and the Nasdaq.
Key slides for ANGLE plc
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
AGL
Country
🇬🇧 United Kingdom